Skip to main content
Clinical Trials/NCT04838678
NCT04838678
Recruiting
Early Phase 1

Sympathetic Neural Patterns and Transduction in Obesity-associated Hypertension

University of Texas Southwestern Medical Center1 site in 1 country100 target enrollmentJuly 18, 2021

Overview

Phase
Early Phase 1
Intervention
Neuropeptide Y
Conditions
Hypertension
Sponsor
University of Texas Southwestern Medical Center
Enrollment
100
Locations
1
Primary Endpoint
Muscle sympathetic nervous system activity
Status
Recruiting
Last Updated
8 months ago

Overview

Brief Summary

The purpose of this study is to understand how the nervous system communicates to blood vessels to increase blood pressure during stress. The study will also investigate how hypertension and obesity influence the nervous system and vascular function. The study will involve measuring sympathetic nervous system activity and blood flow during common laboratory physiological stress protocols (e.g. hypoxia, exercise), and in response to infusion of drugs that cause vasodilation or vasoconstriction.

Registry
clinicaltrials.gov
Start Date
July 18, 2021
End Date
August 31, 2026
Last Updated
8 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Christopher Hearon

Assistant Instructor

University of Texas Southwestern Medical Center

Eligibility Criteria

Inclusion Criteria

  • Control - BMI\<30, age 18-55
  • Hypertensive - BMI\<30, age 18-55, diagnosis of hypertension by 24-hour ambulatory blood pressure monitoring Obese- BMI\>30, age 18-55 Obese-hypertensive- BMI\>30, age 18-55, diagnosis of hypertension by 24-hour ambulatory blood pressure monitoring

Exclusion Criteria

  • All groups - presence of other significant cardiovascular disease, renal disease, history of smoking, diabetes,

Arms & Interventions

Healthy Control

Healthy age matched controls with no history of cardiovascular disease and normal bodyweight

Intervention: Neuropeptide Y

Hypertensive

Hypertensive adults who are not obese

Intervention: Neuropeptide Y

Obese

Obese adults who are not hypertensive

Intervention: Neuropeptide Y

Obese-hypertensive

Obese adults who are being treated for hypertension

Intervention: Neuropeptide Y

Outcomes

Primary Outcomes

Muscle sympathetic nervous system activity

Time Frame: Acutely on the day of study

recording of sympathetic nervous system activity from the peroneal or radial nerve

Blood flow measured by doppler ultrasound

Time Frame: Acutely on the day of study

brachial and femoral artery blood flow

Study Sites (1)

Loading locations...

Similar Trials